Hepion Pharmaceuticals Inc
NASDAQ:HEPA

Watchlist Manager
Hepion Pharmaceuticals Inc Logo
Hepion Pharmaceuticals Inc
NASDAQ:HEPA
Watchlist
Price: 0.135 USD -57.55% Market Closed
Market Cap: 987.7k USD

Net Margin
Hepion Pharmaceuticals Inc

0%
Current
0%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-13.2m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Hepion Pharmaceuticals Inc
Glance View

Market Cap
987.7k USD
Industry
Pharmaceuticals

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. The company is headquartered in Edison, New Jersey and currently employs 20 full-time employees. The company went IPO on 2014-02-07. The firm is focused on the development of drug therapy for treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma (HCC) associated with non-alcoholic steatohepatitis (NASH), viral hepatitis and other liver diseases. The Company’s cyclophilin inhibitor, CRV431, offer benefits to address these multiple complex pathologies. CRV431 is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. The firm has created an AI platform, called AI-POWR, which stands for Artificial Intelligence Precision Medicine Omics World database access and Response and clinical outcomes. The platform helps to identify which NASH patients will best respond to CRV431, potentially shortening development timelines and increasing the delta between placebo and treatment groups.

HEPA Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-13.2m
/
Revenue
0
What is the Net Margin of Hepion Pharmaceuticals Inc?

Based on Hepion Pharmaceuticals Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top